Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alton B. Kremer currently holds 28,171 shares of PROGENICS PHARMACEUTICALS INC (PGNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alton B. Kremer has been a net seller of PGNX stock. They have purchased $0 and sold $239.9K worth of shares.
Alton B. Kremer's most recent insider trade was on Apr 1, 2008, when they sold 3,153 shares at $6.52 per share.
Alton B. Kremer serves as Executive at PROGENICS PHARMACEUTICALS INC (PGNX). They have executed 36 insider transactions totaling $239.9K over their tenure at the company.
Alton B. Kremer holds the position of Executive at PROGENICS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Alton B. Kremer has shown a selling trading pattern, with $0 in total purchases and $239.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Alton B. Kremer was on Jan 30, 2006, when they sold $221.0K worth of PGNX shares. This transaction involved 8,000 shares at $27.63 per share.
Alton B. Kremer currently owns 28,171 shares of PROGENICS PHARMACEUTICALS INC (PGNX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alton B. Kremer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alton B. Kremer has 36 Form 4 filings on record as an insider at PROGENICS PHARMACEUTICALS INC.
Set alerts for Alton B. Kremer and 40,000+ other insiders.